PharmiWeb.com - Global Pharma News & Resources
07-Apr-2021

Anosmia Market Growth to register a CAGR of 6.7% to reach US$ 3,950.3 Million by 2025, Says CMI

SEATTLE, April 07, 2021, (PHARMIWEB) — Overview:

Anosmia, blindness of smell, is the loss of ability to smell. Anosmia may be temporary or permanent. Anosmia is considered as a rare condition, instead of it is probably more common than most people think. According to Fifth Sense, UK, in 2020, various studies and research conducted in many countries show that prevalence of smell loss worldwide is 0.1% to over 5%.

To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/4334

Global Anosmia Market – Impact of Coronavirus (COVID – 19) Pandemic

The COVID-19 epidemic is expected to hinder the growth of the global anosmia market during the forecast period. The COVID-19 epidemic and the devastating effects in various parts of the world have had an impact on the financial situation of businesses in all sectors. The private health sector has been severely affected by the COVID-19 epidemic. The lockdowns have disrupted the supply, distribution and production of medicines around the world.

Furthermore, the coronavirus epidemic has disrupted the development, clinical trials, production, and supply of drugs and other health products and has affected the growth of health care businesses in various companies around the world. According to the Indian Journal of Medical Sciences, June 6, 2020, the COVID-19 pandemic has affected the conduction of clinical trials due to unavailability of trial site staff, restrictions for travelling, investigational product availability, and others. As a result, the impact of the COVID-19 pandemic is expected to limit growth of the global anosmia market during the forecast period.

The global anosmia market is estimated to be valued around US$ 2,500.7 million in 2020 and is expected to register a CAGR of 6.7% over the forecast period (2020-2027).

Figure 1: Global Anosmia Market Share (%) Analysis, By Type, 2020

Drivers:

Rising cases of anosmia is expected to propel growth of the global anosmia market over the forecast period.

Increasing number of anosmia cases is expected to drive the global anosmia market growth over the forecast period. For instance, according to an article published by the ENT UK at The Royal College of Surgeons of England in 2020, reports that novel COVID-19 virus causes anosmia in infected patients.

Moreover, the as per the same source, ENT UK at the Royal College of Surgeons of England in 2020, also reports that 30% of patients in South Korea, have anosmia. Similarly, according to the same source in Germany it is reported that over two-thirds of the confirmed cases have anosmia.

Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4334

Restraints:

Lack of approved medications or drugs for anosmia is a major factor that is expected to hamper global anosmia market growth. Currently, decongestants, antihistamines, and steroid nasal sprays are used off label for the treatment of the anosmia.

Regional Analysis:

Among region, the global anosmia market is segmented into North America, Europe, Latin America, Asia Pacific, Africa, and Middle East,

North America is expected to witness significant growth of the global anosmia market over the forecast period, due to rising anosmia cases in the region. For instance, according to an article published by the National Center for Biotechnology Information (NCBI) in 2017, reports that anosmia affects 3.2% (3.4 million people) of U.S. adults, who are aged above 40 years.

Figure 2: Global Anosmia Market Value (US$ Mn), by Region, 2020

Competitive Landscape:

Some of the major players operating in the global anosmia market such as, Mylan N.V., RANBAXY LABORATORIES LIMITED, Atom Pharma, Alde Medi Impex, Pfizer Inc., Sandoz (Novasrtis AG), GlaxoSmithkline plc, Taj Pharmaceuticals Limited, Inke S.A., and Sanofi, amongst others.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/anosmia-market-3594

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Type
      • Market Snippet, By Treatment
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Key Highlights
    • Product Pipeline
    • Regulatory Scenario
    • Product launch/Approvals
    • PEST Analysis
    • Merger and Acquisition Scenario
    • Market Share Analysis
  4. Anosmia Market – Impact of Coronavirus (Covid-19) Pandemic

    • COVID-19 Epidemiology
    • Supply Side and Demand Side Analysis
    • COVID-19 Impact on the Anosmia
  5. Global Anosmia Market, By Type, 2016 – 2027 (US$ Million)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Idiopathic Anosmia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Congenital Anosmia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  6. Global Anosmia Market, By Treatment, 2016 – 2027 (US$ Million)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Therapies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
        • Nasal Endoscopy
        • Imaging
      • Medications
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
          • Decongestants
          • Antihistamines
          • Steroid Nasal Sprays
  7. Global Anosmia Market, By Region, 2016 – 2027 (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017 – 2027
      • Regional Trends
    • North America
      • Market Size and Forecast, By Type, 2016 – 2027 (US$ Mn)
      • Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027 (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Type, 2016 – 2027 (US$ Mn)
      • Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027 (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Type, 2016 – 2027 (US$ Mn)
      • Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027 (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Type, 2016 – 2027 (US$ Mn)
      • Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027 (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Type, 2016 – 2027 (US$ Mn)
      • Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Type, 2016 – 2027 (US$ Mn)
      • Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2027 (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 07-Apr-2021